Difference between revisions of "Amrubicin (Calsed)"
Jump to navigation
Jump to search
m (categories) |
Warner-admin (talk | contribs) m (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information") |
||
(11 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
− | |||
==General information== | ==General information== | ||
− | Class/mechanism: Synthetic anthracycline | + | Class/mechanism: Synthetic third generation anthracycline and topoisomerase II inhibitor.<ref>[http://www.ds-pharma.com/news/prior/sumitomo_2002/20021206.html Sumitomo Pharmaceuticals Co. press release about launch of amrubicin (Calsed) on 12/6/2002]</ref><ref>[http://www.ds-pharma.com/news/2012/20120905.html Dainippon Sumitomo Pharma submits an application for anticancer antibiotic amrubicin HCI (Brand name in Japan: CALSED®) in China, 9/5/2012]</ref> |
<br>Route: IV | <br>Route: IV | ||
<br>Extravasation: no information | <br>Extravasation: no information | ||
− | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information. |
− | == | + | ==Diseases for which it is used== |
− | *[ | + | *[[Non-small cell lung cancer]] |
− | + | *[[Small cell lung cancer]] | |
− | |||
− | |||
− | *[ | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
==Patient drug information== | ==Patient drug information== | ||
No information available. | No information available. | ||
+ | |||
+ | ==History of changes in PMDA indication== | ||
+ | *2002-04-11: Initial approval for the treatment of [[Small cell lung cancer|small cell]] and [[non-small cell lung cancer]]. | ||
+ | |||
+ | ==Also known as== | ||
+ | *'''Code name:''' SM-5887 | ||
+ | *'''Generic names:''' AMR, amrubicin HCI | ||
+ | *'''Brand name:''' Calsed | ||
==References== | ==References== | ||
<references/> | <references/> | ||
− | [[Category: | + | [[Category:Drugs]] |
− | [[Category: | + | [[Category:Intravenous medications]] |
+ | |||
[[Category:Anthracyclines]] | [[Category:Anthracyclines]] | ||
− | [[Category:Topoisomerase inhibitors]] | + | [[Category:Topoisomerase II inhibitors]] |
+ | [[Category:Non-small cell lung cancer medications]] | ||
+ | [[Category:Small cell lung cancer medications]] | ||
+ | |||
+ | [[Category:PMDA approved drugs]] |
Latest revision as of 01:02, 29 June 2024
General information
Class/mechanism: Synthetic third generation anthracycline and topoisomerase II inhibitor.[1][2]
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.
Diseases for which it is used
Patient drug information
No information available.
History of changes in PMDA indication
- 2002-04-11: Initial approval for the treatment of small cell and non-small cell lung cancer.
Also known as
- Code name: SM-5887
- Generic names: AMR, amrubicin HCI
- Brand name: Calsed